Alternative Health looks at alternative ways of treating illness apart from the medical system.
The first U.S. study of the effect on people of exposure to a hormone-disrupting chemical widely used in food packaging showed that levels the Food and Drug Administration deems “safe” can alter insulin response, a key marker for diabetes. The groundbreaking study, published in the Journal of the Endocrine Society, administered low doses of bisphenol A, or BPA, to 16 people, then tested their insulin production in response to glucose, commonly called blood sugar. When insulin and blood glucose levels were compared to the same measurements taken without exposure to BPA, researchers found that BPA significantly changed how glucose affected insulin levels. Similar insulin and glucose tests are used by doctors for diagnosing diabetes.
Splenda advocates and defenders were given an inconvenient truth from a new study that put the brakes on Splenda’s parade of health claims for marketing purposes. Splenda is the brand name for sucralose. One of the health claims for this chemically-altered sucrose is that its molecules are inert, they don’t produce internal biochemical changes. And even though it sweetens much more efficiently than chemically-unaltered table sugar, it is completely eliminated from the body naturally after ingestion and not stored as fat or even used as energy. Therefore it is calorie free. This most current sucralose animal study turns the claim that it is not stored in the body completely upside down: “The average Splenda users should be informed that sucralose is accumulating in their bodies and that it forms metabolites whose effects are unknown. The long-range effects of sucralose are not understood. Furthermore, we already know that it has adverse biological effects,” stated study author Susan Schiffman, Ph.D. Interestingly, the fact that all the rats in the study gained weight counters claims of non-calorie weight loss that’s promoted with sucralose. The fact that metabolites are formed and detected proves that sucralose is not an inert substance. What those metabolites are, where they are stored, and what dangers they might create, has been addressed by this new study and other studies prior to 2018.
For years, consumers have benefitted from access to cheap, safe, and effective CBD oil supplements. But now the FDA says that CBD is a drug, not a supplement—a drug which will be sold for $32,500 a year. Legally the FDA could at any time remove all CBD supplements from the market, on its own volition, or if the drug company which holds drug market exclusivity requests FDA do so. Unless we change the rules, we may see a government-sponsored monopoly on CBD oil, and in the near future, additional monopolies on other cheap, safe, and effective supplements. This threat to affordable CBD oil shows how broken this system is. An opioid epidemic is ravaging our country, with drug overdose deaths surpassing car accident fatalities. People are addicted to and dying from FDA-approved drugs, yet the agency is poised to eliminate consumer access to a non-addictive, cheap, safe, and effective alternative in CBD oil—all so one drug company can charge tens of thousands of dollars for what currently costs a few dollars. The FDA will not protect us—they’re in on it! More drugs mean more user fees—more money—for the agency, so don’t expect the FDA to defend your access to supplements.
No one really likes to talk about cancer, and childhood cancers are an especially unpalatable topic of conversation. Yet the fact is that cancers are among the top four causes of death for both children and adults. The newest U.S. cancer statistics for young people (under 20 years old), which cover the years 2001–2014, point to steadily increasing rates of pediatric cancer over that time period. Conventional entities such as the American Cancer Society offer no explanation for the increased childhood cancer rates, feebly asserting that “there are few known risk factors for childhood cancer” other than exposure to ionizing radiation. However, this disingenuous statement completely ignores the increasingly toxic environment in which we unreasonably expect children to thrive—and the many known and suspected carcinogens in that environment that may be ratcheting up children’s cancer risks, perhaps synergistically.
A recent animal and human cell line culture study published August, 2018 confirms the anecdotal reports of healing inflammatory bowel and gut conditions with cannabis. Surprisingly, the study did not initially use cannabis. Its original purpose was to investigate the mechanics of inflammation in the gut using mice. They inadvertently discovered that impaired or insufficient internal endogenous cannabinoids known as endocannabinoids in the gut allowed inflammation to occur in the mice. The researchers concluded that adding cannabinoids from cannabis plant sources such as marijuana could be why so many IBS (inflammatory bowel syndrome) and Celiac Disease sufferers experience powerful relief from cannabis. Lead study author McCormick's phrase "This gives clinical researchers a new drug target …" seems to imply that the intent of this study was to develop drugs for the pharmaceutical industry. Natural whole medical cannabis plants, which offer a plethora of disease cures that Big Pharma cannot offer, are not able to be patented. Knowledge of cannabis’s multiple uses is already beginning to impinge on the pharma cartel’s highly profitable medical monopoly, which relies on creating a synthetic version the active pharmacological component of a natural source to patent it. There is hope for sanity to prevail eventually, enabling cannabis to be readily available as a natural medicine for the many ailments and autoimmune diseases once considered incurable by mainstream medicine.
FREE Online Summit for Irritable Bowel Syndrome (IBS) and Small Intestine Bacterial Overgrowth (SIBO)
Irritable Bowel Syndrome (IBS) and small intestine bacterial overgrowth (SIBO) impact more than 400 million people. Symptoms can be painful, embarrassing and isolating, but you’re not alone and there ARE solutions! Left untreated, these pervasive digestion issues can have devastating effects on your quality of life — but there ARE solutions and our world-renowned experts are here to share them! Anyone who suffers from IBS, SIBO, leaky gut or related digestive disorders will benefit greatly from their cutting-edge research and education — information that’s available here first! The IBS & SIBO SOS™ Summit is hosted by health advocate and successful TV personality Shivan Sarna, and it is online and FREE from September 3-10, 2018!
Serrapeptase is a type of proteolytic enzyme. Proteolytic enzymes digest proteins from whole protein foods. But serrapeptase does much more than digest proteins from food. It scavenges unwanted proteins throughout the body, chews up internal organ scar tissue, breaks up plaque deposits, and even destroys cancer cells before they form tumors. Serrapeptase, aka serratiopeptidase, was originally discovered in silkworms that create and use the enzyme to digest the tough mulberry leaves they live on then rapidly bore through their cocoons and fly away as silkmoths when they’re ready. Serrapeptase can function as a safe natural healing agent for many diseases and ailments. It is commonly used in most of Europe to treat sprains and ruptured ligaments and speed up post-operation recovery with less need for pain-killers. Chronic inflammation from autoimmune diseases can be treated with serrapeptase's ability to treat inflammation in tissues throughout the body, including joints and intestines. Removing the dead tissues and excess fibrin ameliorates the body's overacting immune system because the irritant is removed. Then actual healing can result without inflammation or pain. The Western medical serrapeptase pioneer in 1980 was Dr. Hans Nieper. He used serrapeptase for cardiac patients in Germany so successfully that some who had been scheduled for double or triple bypass surgeries managed well without them after using serrapeptase.
If you are among the approximately 50% of adults and teens who feel addicted to smartphones or tablets, then this article about small screen addiction will be a valuable resource to you. If you are a parent who is concerned about the small screen habits of your young children or teen, then you will find helpful information here as well. The combination of addictive apps and small screen devices has a powerful capacity to elevate dopamine levels in the brain. This causes downregulation of the dopamine receptors on brain neurons, which makes it more and more difficult to experience pleasure. Finally, the overstimulation of neurons by dopamine begins killing neurons in the brain, which is a clear sign of physiological addiction. Thus, small screen addiction is very serious – it modifies and damages normal brain activity!
Could the use of colloidal silver, a natural antibiotic that has been used for thousands of years, be a key answer to today's problem of pharmaceutical antibiotic overuse leading to drug-resistant pathogens? The beginning of the end for pharmaceutical antibiotics is blamed on its overuse, both with overly prescribing for humans and overuse with Big Ag and Dairy livestock. This rising problem is known as antibiotic drug resistance. Ironically, the more complex the chemistry of pharmaceutical antibiotics, the easier it is for pathogenic bacteria to figure them out and develop a resistance to them. This has been occurring with almost all pharmaceutical antibiotics. But this phenomena doesn’t exist with natural colloidal silver. Pathogenic bacteria haven't figured out a way around silver even after centuries of use. Before methods of suspending silver particles in distilled water as colloidal silver, silver coins and containers were used to prevent harmful bacteria from forming in the foods, beverages, and water contained. Antibiotics are prescribed even when patients have viral infections, adding to their overuse. Colloidal silver is not only an antibiotic, it is also anti-viral and anti-fungal. Antiviral pharmaceuticals tend to be ineffective and dangerous with huge side effects or long-term lowered immunity and sub-clinical issues created by upsetting the intestinal microbiome balance. So why aren't MDs recommending it?
During active small screen addiction, there is a constant sense of being drawn to the devices and to use certain apps with the hope of gaining fulfillment, satisfaction, and pleasure. In other words, there are cravings that compel people to do certain things with their smartphones and tablets in the hope of getting a dopamine release and feeling good. Checking your phone every few minutes all day long, spending endless hours on apps such as Facebook, preferring to text rather than speak in person, getting up in the middle of the night to check your phone, texting while driving, losing touch with work responsibilities and family obligations are just a few of the symptoms of small screen addiction. As small screen addiction progresses, excessive dopamine levels in the brain cause brain neurons to downregulate their dopamine receptors. This prevents people from experiencing the pleasure they once enjoyed from their small screens. Eventually there is no pleasure, only compulsive use of the small screens, which is an indication that neurons in the brain have begun to die from overstimulation by dopamine. People with out-of-control small screen usage must also realize and admit that they are dealing with an addiction that has the power to control and eventually destroy their lives. This article will focus on raising serotonin in the brain, which will improve the sense of well-being and help to restore contentment and happiness.